Journal of Integrative Cancer Biology

Dr. Raja Singh Paulraj, Ph.D., is a biomedical scientist and Postdoctoral Researcher at Marshall University, USA, with extensive expertise in cancer biology, molecular oncology, and integrative biomedical research. His work focuses on elucidating the molecular mechanisms underlying tumor progression and therapeutic resistance, with a particular emphasis on signaling pathways such as PI3K/Akt, MAPK, and NF-κB in cancer systems.

During his doctoral and postdoctoral research, he has made significant contributions to understanding phytochemical-based cancer therapeutics, particularly the anti-cancer potential of nimbolide in prostate cancer models. His research integrates experimental molecular biology, cell signaling analysis, and translational approaches to identify bioactive compounds targeting oncogenic networks.

Dr. Paulraj has authored numerous peer-reviewed publications in high-impact international journals and has contributed to research spanning prostate cancer, breast cancer, and gastrointestinal oncology-related pathways. He is also actively involved in peer review and editorial activities for multiple international journals across cancer biology, molecular medicine, and pharmacology.

His research interests include tumor genomics, molecular signaling networks, biomarker discovery, multi-omics integration, and phytochemical-based therapeutic strategies. With strong editorial experience and a commitment to scientific rigor, he is well-positioned to lead Journal of Integrative Cancer Biology in advancing high-quality, interdisciplinary cancer research that bridges molecular mechanisms with translational applications.

• Cancer biology and molecular oncology Tumor signaling networks Cancer genomics and functional genomics Biomarker discovery in cancer progression and therapy response Phytochemical-based anticancer therapeutics Molecular mechanisms of apoptosis, autophagy, and cell survival regulation Multi-omics integration in cancer research Translational bioinformatics and precision oncology approaches Tumor microenvironment and therapeutic resistance mechanisms